Medical Care Costs Associated with Cancer Survivorship in the United States.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Angela MariottoK Robin Yabroff

Abstract

The prevalence of cancer survivorship is increasing. In this study, we provide contemporary population-based estimates and projections of the overall and site-specific cancer-attributable medical care costs in the United States. We identified survivors aged ≥65 years diagnosed with cancer between 2000 and 2012 from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database and used 2007 to 2013 claims to estimate costs by cancer site, phases of care, and stage at diagnosis. Annualized average cancer-attributable costs for medical care (Medicare Parts A and B) and oral prescription drugs (Medicare Part D) were estimated by subtracting costs between patients with cancer and matched controls. Costs are reported in 2019 U.S. dollars. We combined phase-specific attributable costs with prevalence projections to estimate national costs from 2015 through 2030. Overall annualized average costs were highest in the end-of-life-cancer death phase, followed by the initial and continuing phases (medical care: $105,500, $41,800, and $5,300 and oral prescription drugs: $4,200, $1,800, $1,100, respectively). There was considerable variation in costs by cancer site and stage. Overall national costs in 2015 were $183 billion and pro...Continue Reading

References

Feb 1, 1992·American Journal of Public Health·E R SatarianoP P Moll
Jan 1, 1989·CA: a Cancer Journal for Clinicians·M H Myers, L A Ries
Oct 31, 2002·Statistics in Medicine·Arduino VerdecchiaRiccardo Capocaccia
Nov 1, 2005·Computer Methods and Programs in Biomedicine·Binbing YuEric J Feuer
Nov 18, 2006·Cancer Causes & Control : CCC·Angela B MariottoMartin Brown
May 1, 2008·Journal of the National Cancer Institute·K Robin YabroffMartin L Brown
Jan 30, 2009·The New England Journal of Medicine·Peter B Bach
Jan 14, 2011·Journal of the National Cancer Institute·Angela B MariottoMartin L Brown
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gery P GuyKatherine S Virgo
Jun 24, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lowell E Schnipper American Society of Clinical Oncology
Jun 24, 2015·Cancer·Jagpreet ChhatwalHagop Kantarjian
Feb 24, 2016·Medical Care·Cathy J BradleyElizabeth B Lamont
Jun 2, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lowell E SchnipperRichard L Schilsky
Jul 3, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Shirley M BluethmannJulia H Rowland
Jan 4, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cathy J BradleyJoan L Warren
Apr 5, 2017·Journal of the National Cancer Institute·Ahmedin JemalHannah K Weir
Apr 11, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·Matthew P BanegasMark C Hornbrook
Aug 30, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Miranda B LamAshish K Jha
Jun 12, 2019·CA: a Cancer Journal for Clinicians·Kimberly D MillerRebecca L Siegel
May 16, 2020·Journal of the National Cancer Institute. Monographs·Angela B MariottoK Robin Yabroff

❮ Previous
Next ❯

Citations

Nov 26, 2020·Cancer·Michael T HalpernJoseph Lipscomb
Jan 12, 2021·The American Journal of Hospice & Palliative Care·Paige E SheridanJames D Murphy
Feb 10, 2021·JAMA : the Journal of the American Medical Association·Stacie B Dusetzina
Dec 31, 2020·Gynecologic Oncology·Margaret I LiangJason D Wright
Mar 4, 2021·Journal for Immunotherapy of Cancer·Thomas U MarronJennifer L Guerriero
Mar 21, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ulrike BoehmerKevan Hartshorn
Mar 23, 2021·JAMA Network Open·Bogdana Schmidt, John T Leppert
Apr 12, 2021·Journal of the National Cancer Institute·Anne Kirchhoff, Salene Jones
Apr 20, 2021·Frontiers in Oncology·Davis W CrewsMichael R King
Jun 12, 2021·Preventing Chronic Disease·Hannah K WeirMary C White
Jun 9, 2021·Cancer Medicine·Hannah S ThomasBenjamin N Breyer
Jun 15, 2021·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Mir-Masoud PourrahmatKaren C Chung
Jun 17, 2021·JAMA Network Open·Kirbi L YelordaDouglas K Owens
Jun 22, 2021·Journal of Cancer Survivorship : Research and Practice·Courtney P WilliamsMaria Pisu
Jul 3, 2021·International Journal of Environmental Research and Public Health·Florencia Borrescio-Higa, Nieves Valdés
Jul 6, 2021·Translational Behavioral Medicine·Patricia G WolfLisa Tussing-Humphreys
Jul 13, 2021·Healthcare : the Journal of Delivery Science and Innovation·Bian LiuEmanuela Taioli
Jul 24, 2021·Future Oncology·Alexander H GunnRachel A Greenup
Aug 13, 2021·JCO Oncology Practice·Bonnie E Gould RothbergKerin B Adelson
Aug 22, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Talya GordonAlyssa T Brooks
Aug 28, 2021·Cancers·Francesco Monticolo, Maria Luisa Chiusano
Aug 26, 2021·Journal of Gynecologic Oncology·Burak ZeybekVaagn Andikyan
Aug 31, 2021·Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches·Miranda B LamLaura G Burke
Sep 23, 2021·Journal of the National Comprehensive Cancer Network : JNCCN·Terrell JohnsonRobert W Carlson
Oct 7, 2021·JAMA Network Open·Carolyn Y Fang, Zachary A K Frosch
Jul 8, 2021·American Journal of Preventive Medicine·Waseem KhaliqScott M Wright
Oct 27, 2021·Journal of the National Cancer Institute·K Robin YabroffElizabeth M Ward
Oct 27, 2021·Journal of the National Cancer Institute·Ya-Chen Tina Shih, Joseph Lipscomb
Nov 9, 2021·Journal of Basic Microbiology·Aqsa ShahidMuhammad Waseem
Nov 10, 2021·JAMA : the Journal of the American Medical Association·Nancy L KeatingUNKNOWN Oncology Care Model Evaluation Team
Nov 10, 2021·JAMA : the Journal of the American Medical Association·Raymond U OsarogiagbonDeborah Schrag
Nov 8, 2021·Journal of the National Cancer Institute·Paul Brennan, George Davey Smith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.